The real-time PCR (qPCR) segment by type is estimated to lead the market growth during the forecast period.
According to a new market research study of “North America PCR for Respiratory Infection Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, Product Type, Infection Type, End-user and Country.” The North America PCR for respiratory infection diagnostics market is expected to reach US$ 3,581.63 million by 2028 from US$ 1,766.10 million in 2021; it is estimated to grow at a CAGR of 10.6% from 2021 to 2028. The report highlights trends prevailing in the North America PCR for respiratory infection diagnostics market and the factors driving market along with those that act as hindrances. The growth of the market is determined due to some of the key driving factors, such as increasing burden of chronic respiratory diseases (CRDs) and growing developments in PCR testing, are expected to propel the growth of the market. However, availability of alternative assays is the major factor hindering the market growth.
Chronic respiratory diseases (CRDs) are among the leading causes of morbidity globally due to the heavy consumption of tobacco. For instance, according to the WHO, in 2018, the fourth largest cause of mortality in the US was chronic lower respiratory illness, predominantly COPD. Nearly 15.7 million Americans (6.4%) have been diagnosed with COPD. The burden of CRDs is expected to increase in the future due to poor air quality, increase in addiction to smoking, and rise in geriatric population that is more prone to COPD and lung cancer. Moreover, programs initiated in the countries to improve treatment and support the people living with respiratory diseases are likely to increase the demand for PCR for the diagnosis of respiratory diseases. This will lead to the market growth during the forecast period. The demand for PCR testing to diagnose infectious diseases has significantly risen in the past few years. The growing technological advancements have added an extra advantage of point-of-care testing through PCR, which has surged the demand for PCR diagnostics. In addition, the demand has exponentially raised due to the outbreak of COVID-19. Since the pandemic has initiated, reverse transcription-polymerase reaction (RT-PCR) test has been preferably used to diagnose and examine the genetic material of SARS-CoV-2 RNA. The RT-PCR method is widely accepted as the gold standard for the detection of SARS-CoV-2 RNA due to its sensitive testing. Therefore, considering the demand for PCR testing, various market players have introduced PCR products and entered strategic developments in the global market. Also, most companies are now offering real-time polymerase chain reaction (PCR) tests for COVID-19, which is contributing to the growth of the target market.
COVID-19 pandemic has served vital growth opportunities for the PCR for respiratory infection diagnostics market. The market has experienced exponential growth during the pandemic due to tremendous demand for COVID-19 testing through PCR. North America is the leading market that has significantly contributed to the growth of the market. There have been various factors, including increased incidences of COVID-19 positive patients, growth in PCR technologies, increasing production of reagents and kits, and many other factors. The cases majorly led to the demand for PCR testing in the countries such as the US, Canada, and Mexico. In addition, companies such as Omega Laboratories and LaunchWorks are launching various PCR testing in countries expanding the services, due to increasing demand from governments, communities, and organizations to track and control the spread of the virus.
The North America PCR for respiratory infection diagnostics market, by type, is segmented into real time PCR (qPCR), traditional PCR, reverse-transcriptase (RT-PCR), digital PCR, multiplex PCR, and others. Based on product type, the North America PCR for respiratory infection diagnostics market is segmented into reagents and kits, instruments, and others. Based on infection type, the North America PCR for respiratory infection diagnostics market is segmented into bacterial infection, viral infection, and fungal & other pathogens. The bacterial infection segment is further divided into bordetella, streptococcus pneumoniae, staphylococcus aureus, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydophila pneumoniae, legionella and others. Additionally, the viral infection segment is further bifurcated into rhinoviruses, influenza virus, severe acute respiratory syndrome (sars) cov-2 virus, respiratory syncytial virus (rsv), adenovirus, enterovirus, parainfluenza, human metapneumovirus (hmpv) and others. Futher, based on End-user, the North America PCR for respiratory infection diagnostics market is segmented into hospitals, physician clinics, clinical laboratories, academic and research institutions, biotech and pharma companies, and others. Geographically, the North America PCR for respiratory infection diagnostics market can be segmented into U.S, Mexico and Canada.
Abbott, F. HOFFMANN-LA ROCHE LTD, Hologic, Inc. BD, BIO-RAD LABORATORIES INC. bioMerieux SA, QIAGEN, Thermo Fisher Scientific Inc. and Seegene Incare among the leading companies operating in the North America PCR for respiratory infection diagnostics market
Chronic respiratory diseases (CRDs) are among the leading causes of morbidity globally due to the heavy consumption of tobacco. For instance, according to the WHO, in 2018, the fourth largest cause of mortality in the US was chronic lower respiratory illness, predominantly COPD. Nearly 15.7 million Americans (6.4%) have been diagnosed with COPD. The burden of CRDs is expected to increase in the future due to poor air quality, increase in addiction to smoking, and rise in geriatric population that is more prone to COPD and lung cancer. Moreover, programs initiated in the countries to improve treatment and support the people living with respiratory diseases are likely to increase the demand for PCR for the diagnosis of respiratory diseases. This will lead to the market growth during the forecast period. The demand for PCR testing to diagnose infectious diseases has significantly risen in the past few years. The growing technological advancements have added an extra advantage of point-of-care testing through PCR, which has surged the demand for PCR diagnostics. In addition, the demand has exponentially raised due to the outbreak of COVID-19. Since the pandemic has initiated, reverse transcription-polymerase reaction (RT-PCR) test has been preferably used to diagnose and examine the genetic material of SARS-CoV-2 RNA. The RT-PCR method is widely accepted as the gold standard for the detection of SARS-CoV-2 RNA due to its sensitive testing. Therefore, considering the demand for PCR testing, various market players have introduced PCR products and entered strategic developments in the global market. Also, most companies are now offering real-time polymerase chain reaction (PCR) tests for COVID-19, which is contributing to the growth of the target market.
COVID-19 pandemic has served vital growth opportunities for the PCR for respiratory infection diagnostics market. The market has experienced exponential growth during the pandemic due to tremendous demand for COVID-19 testing through PCR. North America is the leading market that has significantly contributed to the growth of the market. There have been various factors, including increased incidences of COVID-19 positive patients, growth in PCR technologies, increasing production of reagents and kits, and many other factors. The cases majorly led to the demand for PCR testing in the countries such as the US, Canada, and Mexico. In addition, companies such as Omega Laboratories and LaunchWorks are launching various PCR testing in countries expanding the services, due to increasing demand from governments, communities, and organizations to track and control the spread of the virus.
The North America PCR for respiratory infection diagnostics market, by type, is segmented into real time PCR (qPCR), traditional PCR, reverse-transcriptase (RT-PCR), digital PCR, multiplex PCR, and others. Based on product type, the North America PCR for respiratory infection diagnostics market is segmented into reagents and kits, instruments, and others. Based on infection type, the North America PCR for respiratory infection diagnostics market is segmented into bacterial infection, viral infection, and fungal & other pathogens. The bacterial infection segment is further divided into bordetella, streptococcus pneumoniae, staphylococcus aureus, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydophila pneumoniae, legionella and others. Additionally, the viral infection segment is further bifurcated into rhinoviruses, influenza virus, severe acute respiratory syndrome (sars) cov-2 virus, respiratory syncytial virus (rsv), adenovirus, enterovirus, parainfluenza, human metapneumovirus (hmpv) and others. Futher, based on End-user, the North America PCR for respiratory infection diagnostics market is segmented into hospitals, physician clinics, clinical laboratories, academic and research institutions, biotech and pharma companies, and others. Geographically, the North America PCR for respiratory infection diagnostics market can be segmented into U.S, Mexico and Canada.
Abbott, F. HOFFMANN-LA ROCHE LTD, Hologic, Inc. BD, BIO-RAD LABORATORIES INC. bioMerieux SA, QIAGEN, Thermo Fisher Scientific Inc. and Seegene Incare among the leading companies operating in the North America PCR for respiratory infection diagnostics market
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America PCR for respiratory infection diagnostics market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America PCR for respiratory infection diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America PCR for Respiratory Infection Diagnostics Market - By Type
1.3.2 North America PCR for Respiratory Infection Diagnostics Market - By Product Type
1.3.3 North America PCR for Respiratory Infection Diagnostics Market - By Infection Type
1.3.4 North America PCR for Respiratory Infection Diagnostics Market - By End User
1.3.5 North America PCR for Respiratory Infection Diagnostics Market - By Country
2. North America PCR for Respiratory Infection Diagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. PCR for Respiratory Infection Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.3 Experts Opinion
5. PCR for Respiratory Infection Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Burden of Chronic Respiratory Diseases (CRDs)
5.1.2 Growing Developments in PCR Testing
5.2 Market Restraints
5.2.1 Availability of Alternative Assays
5.3 Market Opportunities
5.3.1 Use of PCR Testing for Various Respiratory Infection Diagnostics
5.4 Future Trends
5.4.1 Developments in PCR Technology
5.5 Impact analysis
6. PCR for Respiratory Infection Diagnostics Market - North America Analysis
6.1 North America PCR for Respiratory Infection Diagnostics Market Revenue Forecast and Analysis
7. PCR for Respiratory Infection Diagnostics Market Analysis by Type
7.1 Overview
7.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Real Time PCR (qPCR)
7.3.1 Overview
7.3.2 Real Time PCR (qPCR): PCR for Respiratory Infection Diagnostics market - Revenue and Forecast to 2028 (US$ Million)
7.4 Multiplex PCR
7.4.1 Overview
7.4.2 Multiplex PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Traditional PCR
7.5.1 Overview
7.5.2 Traditional PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Digital PCR
7.6.1 Overview
7.6.2 Digital PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Reverse Transcriptase (RT-PCR)
7.7.1 Overview
7.7.2 Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8. PCR for Respiratory Infection Diagnostics Market Analysis - By Product Type
8.1 Overview
8.2 PCR for Respiratory Infection Diagnostics Market, by Product Type 2021 & 2028 (%)
8.3 Reagents and kits
8.3.1 Overview
8.3.2 Reagents and Kits: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: PCR for respiratory infection diagnostics market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9. PCR for Respiratory Infection Diagnostics Market - By Infection Type
9.1 Overview
9.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Infection Type, 2021 & 2028 (%)
9.3 Bacterial Infections
9.3.1 Overview
9.3.2 Bacterial Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.3 Bordetella
9.3.3.1 Overview
9.3.3.2 Bordetella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.4 Streptococcus Pneumoniae
9.3.4.1 Overview
9.3.4.2 Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.5 Staphylococcus Aureus
9.3.5.1 Overview
9.3.5.2 Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.6 Haemophilus Influenzae
9.3.6.1 Overview
9.3.6.2 Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.7 Moraxella Catarrhalis
9.3.7.1 Overview
9.3.7.2 Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.8 Mycoplasma Pneumoniae
9.3.8.1 Overview
9.3.8.2 Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.9 Chlamydophila Pneumoniae
9.3.9.1 Overview
9.3.9.2 Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.10 Legionella
9.3.10.1 Overview
9.3.10.2 Legionella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.11 Others
9.3.11.1 Overview
9.3.11.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4 Viral Infection
9.4.1 Overview
9.4.2 Viral Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.3 Rhinoviruses
9.4.3.1 Overview
9.4.3.2 Rhinoviruses: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.4 Influenza Virus
9.4.4.1 Overview
9.4.4.2 Influenza Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.5 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
9.4.5.1 Overview
9.4.5.2 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.6 Respiratory Syncytial Virus (RSV)
9.4.6.1 Overview
9.4.6.2 Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.7 Adenovirus
9.4.7.1 Overview
9.4.7.2 Adenovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.8 Enterovirus
9.4.8.1 Overview
9.4.8.2 Enterovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.9 Parainfluenza
9.4.9.1 Overview
9.4.9.2 Parainfluenza: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.10 Human Metapneumovirus (hMPV)
9.4.10.1 Overview
9.4.10.2 Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.11 Others
9.4.11.1 Overview
9.4.11.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5 Fungal and Other Pathogens
9.5.1 Overview
9.5.2 Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10. PCR for Respiratory Infection Diagnostics Market - By End User
10.1 Overview
10.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by End User (2021 and 2028)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4 Physician Clinics
10.4.1 Overview
10.4.2 Physician Clinics: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5 Clinical Laboratories
10.5.1 Overview
10.5.2 Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.6 Academic and Research Institutions
10.6.1 Overview
10.6.2 Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.7 Biotech and Pharma Companies
10.7.1 Overview
10.7.2 Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.8 Others
10.8.1 Overview
10.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11. PCR for Respiratory Infection Diagnostics Market - North America Analysis
11.1 North America: PCR for Respiratory Infection Diagnostics Market
11.1.1 Overview
11.1.2 North America: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
11.1.2.1 US: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 US: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 US: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.3 US: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4 US: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4.1 US: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4.2 US: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.2.1.5 US: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.2.2 Canada: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 Canada: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 Canada: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.3 Canada: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4 Canada: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4.1 Canada: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4.2 Canada: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.2.2.5 Canada: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.2.3 Mexico: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 Mexico: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 Mexico: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.3 Mexico: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4 Mexico: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4.1 Mexico: PCR for Respiratory Infection Diagnostics Market, by Viral Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4.2 Mexico: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5 Mexico: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on North America PCR for Respiratory Infection Diagnostics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. PCR For Respiratory Infection Diagnostics Market-Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Hologic, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 BD
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 bioMerieux SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 QIAGEN
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Thermo Fisher Scientific Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Seegene Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About
15.2 Glossary of Terms
List of Tables
Table 1. US PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 2. US PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 3. US PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 4. US PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 5. US PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 6. US PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 7. Canada PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 12. Canada PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico PCR for Respiratory Infection Diagnostics Market, by Viral Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico PCR for Respiratory Infection Diagnostics Market, by Bacterial Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 19. Recent Inorganic Growth Strategies in the PCR for Respiratory Infection Diagnostics Market
Table 20. Recent Organic Growth Strategies in the PCR for Respiratory Infection Diagnostics Market
Table 21. Glossary of Terms, PCR for Respiratory Infection Diagnostics MarketList of Figures
Figure 1. PCR for Respiratory Infection Diagnostics Market Segmentation
Figure 2. PCR for Respiratory Infection Diagnostics Market Segmentation, By Country
Figure 3. North America PCR for Respiratory Infection Diagnostics Market Overview
Figure 4. Real-Time PCR (qPCR) Segment Held Largest Share of Type Segment in PCR for Respiratory Infection Diagnostics Market
Figure 5. North America PCR for Respiratory Infection Diagnostics Market - Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. PCR for Respiratory Infection Diagnostics Market Impact Analysis of Driver and Restraints
Figure 8. North America PCR for Respiratory Infection Diagnostics Market - Revenue Forecast and Analysis - 2020 - 2028
Figure 9. PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2021 and 2028)
Figure 10. Real Time PCR (qPCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Multiplex PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Traditional PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Digital PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. PCR for Respiratory Infection Diagnostics Market, by Product Type 2021 & 2028 (%)
Figure 17. Reagents and Kits: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Instruments: PCR for respiratory infection diagnostics market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. PCR for Respiratory Infection Diagnostics Market Share, by Infection Type, 2021 & 2028 (%)
Figure 21. Bacterial Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 22. Bordetella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 23. Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 24. Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 25. Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 26. Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 27. Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 28. Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 29. Legionella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 30. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Viral Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Rhinoviruses: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 33. Influenza Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 36. Adenovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 37. Enterovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 38. Parainfluenza: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 39. Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 40. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. PCR for Respiratory Infection Diagnostics Market Share, by End User, 2021 and 2028 (%)
Figure 43. Hospitals: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. Physician Clinics: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. North America: PCR for Respiratory Infection Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 50. North America: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 51. US: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 52. Canada: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 53. Mexico: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 54. Impact of COVID-19 Pandemic in North American Country Markets
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- F. HOFFMANN-LA ROCHE LTD
- Hologic, Inc.
- BD
- Bio-Rad Laboratories Inc.
- bioMerieux SA
- QIAGEN
- Thermo Fisher Scientific Inc.
- Seegene Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 201 |
| Published | July 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 1766.1 Million |
| Forecasted Market Value ( USD | $ 3581.63 Million |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | North America |
